연구동향 분석

Pharmacogenetic predictors of pharmacokinetics and lipid lowering pharmacodynamics of atorvastatin in healthy Korean subjects = 건강한 한국인 피험자에서의 Atorvastatin의 유전적 다형성과 약동력학적 특성 간 상관성 연구

김세림 2020년

논문상세정보
인용/피인용
' Pharmacogenetic predictors of pharmacokinetics and lipid lowering pharmacodynamics of atorvastatin in healthy Korean subjects = 건강한 한국인 피험자에서의 Atorvastatin의 유전적 다형성과 약동력학적 특성 간 상관성 연구' 의 주제별 논문영향력
논문영향력 선정 방법
논문영향력 요약
주제
  • Lipid-lowering response
  • Next generation sequencing
  • Pharmacokinetic parameter
  • atorvastatin
  • liquidchromatography-tandemmassspectrometry
  • pharmacogenetics
동일주제 총논문수 논문피인용 총횟수 주제별 논문영향력의 평균
153 0

0.0%

' Pharmacogenetic predictors of pharmacokinetics and lipid lowering pharmacodynamics of atorvastatin in healthy Korean subjects = 건강한 한국인 피험자에서의 Atorvastatin의 유전적 다형성과 약동력학적 특성 간 상관성 연구' 의 참고문헌

  • pharmacogenomics of statin treatment. Pharmacogenomics J. 2006;6(6):360- 74.
  • dbNSFP v3.0 : A One-Stop Database of Functional Predictions and Annotations for Human Nonsynonymous and Splice-Site SNVs
    37 ( 3 ) :235-41 . [2016]
  • X. Optimal tests for rare variant effects in sequencing association studies
    13 ( 4 ) :762-75 . [2012]
  • Warfarin Anticoagulation Therapy in Caribbean Hispanics of Puerto Rico : ACandidate Gene Association Study
    7 ( 8 ) :347 . [2017]
  • Variation in the 3-hydroxyl-3methylglutaryl coenzyme a reductase gene is associated with racial differences in low-density lipoprotein cholesterol response to simvastatin treatment
    117 ( 12 ) :1537-44 . [2008]
  • Transporter genes ABCG2 rs2231142 and ABCB1 rs1128503 polymorphisms and atorvastatin response in Chilean subjects
    43 ( 1 ) :87-91 . [2018]
  • The ensembl variant effect predictor
    17 ( 1 ) :122 . [2016]
  • The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease : meta-analysis of individual data from 27 randomised trials
    380 ( 9841 ) :581-90 . [2012]
  • The clinical pharmacogenetics implementation consortium guideline for SLCO1B1 and simvastatin-induced myopathy : 2014 update .
    96 ( 4 ) :423-8 . [2014]
  • The Genome Analysis Toolkit : a MapReduce framework for analyzing next-generation DNA sequencing data
    20 ( 9 ) :1297-303 . [2010]
  • Systemic exposure to atorvastatin between Asian and Caucasian subjects : a combined analysis of 22 studies
    19 ( 3 ) :164-73 . [2012]
  • Statin-associated muscle symptoms : impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment , Aetiology and Management
    36 ( 17 ) :1012-22 . [2015]
  • Statin therapy increases lipoprotein ( a ) levels
    20 : ehz310 . [2019]
  • Statin therapy and plasma free fatty acids : a systematic review and meta-analysis of controlled clinical trials
    81 ( 5 ) :807-18 [2016]
  • Statin safety : a systematic review
    97 ( 8A ) :52C-60C . [2006]
  • Statin myotoxicity : a review of genetic susceptibility factors
    24 ( 1 ) :4-15 . [2014]
  • Severe hypercholesterolemia in four British families with the D374Y mutation in the PCSK9 gene : long-term follow-up and treatment response
    25 ( 12 ) :2654-60 . [2005]
  • Seventeen years of statin pharmacogenetics : a systematic review
    17 ( 2 ) :163- 80 . [2016]
  • RHOA is a modulator of theCholesterol-lowering effects of statin .
    8 ( 11 ) : e1003058 . [2012]
  • Polymorphism in KIF6 gene and benefit from statins after acuteCoronary syndromes : results from the PROVE IT-TIMI 22 study .
    51 ( 4 ) :449-55 . [2008]
  • Pharmacogenomics of statins : understanding susceptibility to adverse effects .
    3 ( 9 ) :97-106 . [2016]
  • Pahan K. Lipid-lowering drugs
    63 ( 10 ) :1165-78 [2006]
  • PLINK : a tool set for whole-genome association and population-based linkage analyses
    81 ( 3 ) :559-75 . [2007]
  • Molecular aspects of hypercholesterolemia treatment : current perspectives and hopes
    50 ( 4 ) :303-311 . [2018]
  • Mild to moderate muscular symptoms with high-dosage statin therapy in hyperlipidemic patients -- the PRIMO study
    19 ( 6 ) :403-14 . [2005]
  • Mechanisms of statin-induced myalgia assessed by physiogenomic associations .
    218 ( 2 ) :451-6 . [2011]
  • List of variants in gene APOB studied for Familial hypobetalipoproteinemia. ClinVar Miner website.https://clinvarminer.genetics.utah.edu/variants-bygene/APOB/condition/Familial%20hypobetalipoproteinemia. Accessed Feb 27, 2020.
  • Lipid-lowering efficacy of atorvastatin
    12 ( 3 ) : CD008226 . [2015]
  • KIF6 gene as a pharmacogenetic marker for lipid-lowering effect in statin treatment .
    13 ( 10 ) : e0205430 . [2018]
  • KIF6 719Arg allele is associated with statin effects on cholesterol levels in amnestic mild cognitive impairment and Alzheimer 's disease patients .
    33 ( 1 ) :111-6 . [2013]
  • Jones P. Effects of statins on high-density lipoproteins : a potential contribution to cardiovascular benefit .
    22 ( 4 ) :321-38 . [2008]
  • Intronic polymorphism in CYP3A4 affects hepatic expression and response to statin drugs
    11 ( 4 ) :274-86 . [2011]
  • Inherited variation in the xenobiotic transporter pathway and survival of multiple myeloma patients
    183 ( 3 ) :375-384 [2018]
  • Inherited variation in the ATP- binding cassette transporter ABCB1 and survival after chemotherapy for stage III-IV lung cancer .
    9 ( 9 ) :1264-71 . [2014]
  • Impact of apolipoprotein A5 variants on statin treatment efficacy
    10 ( 6 ) :945-50 . [2009]
  • Impact of Pharmacogenetics on Efficacy and Safety of Statin Therapy for Dyslipidemia
    37 ( 9 ) :1172-1190 . [2017]
  • Imatinib-induced ophthalmological sideeffects in GIST patients are associated with the variations of EGFR , SLC22A1 , SLC22A5 and ABCB1
    18 ( 3 ) :460-466 . [2018]
  • Genetic variation in the ABCC2 gene is associated with dose decreases or switches to other cholesterol-lowering drugs during simvastatin and atorvastatin therapy
    13 ( 3 ) :251-6 . [2013]
  • Genetic involvement in statins induced myopathy . Preliminary data from an observational case-control study
    211 ( 1 ) :28-9 . [2010]
  • Genetic factors affecting statin concentrations and subsequent myopathy : a HuGENet systematic review
    16 ( 11 ) :810-9 . [2014]
  • Genetic association of NOS1 exon18 , NOS1 exon29 , ABCB1 1236C/T , and ABCB1 3435C/T polymorphisms with the risk of Parkinson 's disease : A meta-analysis
    95 ( 40 ) : e4982 . [2016]
  • Efficacy and tolerability of two different formulations of atorvastatin in Korean patients with hypercholesterolemia : a multicenter , prospective , randomized clinical trial
    2 ( 11 ) :2277-2285 . [2017]
  • Effects of normalization on quantitative traits in association test
    14 ( 10 ) :415 [2009]
  • Effect of two lipid-lowering strategies on high-density lipoprotein function and some HDL-related proteins : a randomized clinical trial
    16 ( 1 ) :49 . [2017]
  • Effect of fenofibrate and atorvastatin on VLDL apoE metabolism in men with the metabolic syndrome
    53 ( 11 ) :2443-9 . [2012]
  • Effect of concomitant icosapent ethyl ( eicosapentaenoic acid ethyl ester ) on the pharmacokinetics of atorvastatin
    35 ( 1 ) :45-51 . [2015]
  • Effect of atorvastatin on plasma apoE metabolism in patients with combined hyperlipidemia
    43 ( 9 ) :1464-71 . [2002]
  • Effect of ABCB1 genetic polymorphisms on the transport of rivaroxaban in HEK293 recombinant cell lines
    8 ( 1 ) :10514 . [2018]
  • Association of genetic variations with pharmacokinetics and lipid-lowering response to atorvastatin in healthy Korean subjects
    4 ( 11 ) :1135-1146 . [2017]
  • Association of Genetic Variants Related to CETP Inhibitors and Statins With Lipoprotein Levels and Cardiovascular Risk
    318 ( 10 ) :947-956 . [2017]
  • Association of ABCC2 polymorphism and gender with high-density lipoprotein cholesterol response to simvastatin
    19 ( 14 ) :1125-1132 . [2018]
  • ACC/AHA Guideline on the Primary Prevention of Cardiovascular Disease : A Report of the American College of Cardiology/American Heart Association Task Force on Clinical Practice Guidelines
    140 ( 11 ) : e596-e646 [2019]
  • ABCB1/MDR1 gene polymorphisms as a prognostic factor in colorectal cancer
    25 ( 10 ) :1167-76 . [2010]
  • ABCB1 gene variants and antidepressant treatment outcome : A meta-analysis
    168B ( 4 ) :274-83 . [2015]
  • A statin-dependent QTL for GATM expression is associated with statin-induced myopathy .
    502 ( 7471 ) :377–380 . [2013]
  • A framework for variation discovery and genotyping using nextgeneration DNA sequencing data
    43 ( 5 ) :491-8 [2011]
  • 1236 C/T and 3435 C/T polymorphisms of the ABCB1 gene in Mexican breast cancer patients .
    14 ( 1 ) :1250-9 . [2015]